Clinical Trials Logo

Filter by:
NCT ID: NCT06003439 Completed - Smoking Cessation Clinical Trials

Vaping Prevention and Vaping in Youth (Vapechat)

Vapechat
Start date: April 4, 2024
Phase: N/A
Study type: Interventional

Many youth are addicted to nicotine due to increased nicotine vaping (e.g., e-cigarettes). Unfortunately, there are no effective interventions to help teens quit vaping. In addition, existing vaping prevention programs have limited effectiveness because teens have reported that existing available interventions are out of touch with teen's culture and are not appealing to the intended audience. Therefore, to be effective, a vaping intervention must be acceptable, appealing, and engaging to teens, and most importantly, it should be designed to be channeled into an existing infrastructure such as the school setting. The investigators' research group has designed a vaping prevention and cessation intervention that is implemented as a VR game for high school teens. The overall objective of this research is to assess the acceptability, feasibility, and preliminary efficacy of the VR experience among high school students in two high schools in Boston.

NCT ID: NCT06003361 Completed - Clinical trials for Major Depressive Disorder

Rise Study for Depression

Start date: August 31, 2023
Phase: N/A
Study type: Interventional

This study will examine the efficacy of digital CBT versus waitlist in improving symptoms for adults with Major Depressive Disorder.

NCT ID: NCT06002347 Completed - Bullying Clinical Trials

Middle School Parent Module for a Brief Bullying Intervention Program

Start date: April 5, 2022
Phase: N/A
Study type: Interventional

This study evaluates the feasibility and short-term outcomes of a parent training designed as a companion module to a bullying bystander intervention (STAC) for middle school students in rural communities. The aim of this project is to provide a brief, low-cost intervention that can be easily disseminated as part of a school-based bullying prevention program to address this important public health problem.

NCT ID: NCT06001866 Completed - Clinical trials for Language Development

Retrieval-Based Word Learning in Developmental Language Disorder: Verb Learning

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

Children with developmental language disorder (DLD; also referred to as specific language impairment) experience a significant deficit in language ability that is longstanding and harmful to the children's academic, social, and eventual economic wellbeing. Word learning is one of the principal weaknesses in these children. This project focuses on the word learning abilities of four- and five-year-old children with DLD. The goal of the project is to build on the investigators' previous work to determine whether, as has been found thus far, special benefits accrue when these children must frequently recall newly introduced words during the course of learning. The focus of the current study is verb-learning. The goal of the study is to increase children's absolute levels of learning while maintaining the advantage that repeated retrieval holds over comparison methods of learning.

NCT ID: NCT06000332 Completed - Nocturnal Hypoxemia Clinical Trials

Evaluation of POC Pulse-dose Demand Oxygen Delivery for Nocturnal Hypoxemia

Start date: October 17, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to describe the effect of the Inogen Rove 6 Portable Oxygen Concentrator on peripheral oxygen saturation in adults receiving supplemental oxygen at night and examine whether the device can adequately maintain oxygen saturation during sleep.

NCT ID: NCT05999513 Completed - Clinical trials for Healthy Participants

A Relative Bioavailability Study and Food Effect Study of AB521 in Healthy Adult Volunteers

ARC-28
Start date: August 21, 2023
Phase: Phase 1
Study type: Interventional

The primary purpose of this study is to compare the single-dose pharmacokinetics (PK) of AB521 tablet versus the AB521 capsule, and to evaluate the effect of food on the single-dose PK of AB521 tablet in healthy adult volunteers.

NCT ID: NCT05998967 Completed - PTSD Clinical Trials

Pilot Trial of Mobile Mantram Delivery

mMRP
Start date: December 1, 2021
Phase: N/A
Study type: Interventional

Mantram Repetition Program (MRP) is a meditation practice that involves silent repetition of a spiritual word, one-pointed attention, and slowing down. It has been shown to help reduce PTSD symptoms among Veterans. This study will look at how Veterans reach to learning MRP via the Internet, either in a self-directed way or with text/phone support.

NCT ID: NCT05998148 Completed - Surgery Clinical Trials

Virtual Phone Visits Compared to In-Person Physical Visits for Post-Operative Follow-Up at a Sports Medicine Clinic

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

This study will compare patient reported outcomes (PROs) and patient satisfaction scores of patients seen at virtual phone visits with patients seen at in-person visits for post-operative follow up at 6 weeks, 12 weeks, and 6 months at a sports medicine clinic. This study will determine if there is a difference in PROs and satisfaction scores between these two groups of patients. The investigators hypothesize patients who are seen during a virtual phone visit will report different PRO and patient satisfaction scores compared to patients who are seen during an in-person visit for post-operative follow-up at 6 weeks, 12 weeks, and 6-months.

NCT ID: NCT05998096 Completed - Cognition Clinical Trials

A Randomized Study to Examine the Ability of a Caffeine-Based Energy Drink to Impact Energy Expenditure, Fat Oxidation, Reaction Time, and Other Perceptual Indicators

ASH
Start date: September 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the changes in energy expenditure, fat oxidation, reaction time, and perceptual indicators of energy and focus after acute ingestion of a caffeine-based energy drink. Approximately 60 healthy adults aged 18-50 will be recruited for a randomized, double-blind, placebo-controlled study. They will undergo baseline measurements for energy expenditure, fat and carbohydrate oxidation, reaction time, cognition, and perceptual indicators of energy, focus, and concentration. After 28 days, these measurements will be taken again, comparing the effects of a caffeine-based energy drink versus a placebo.

NCT ID: NCT05997888 Completed - Physical Inactivity Clinical Trials

Feasibility, Acceptability, and Preliminary Efficacy of a Six-week Physical Activity Intervention for Black Women

Start date: November 27, 2023
Phase: N/A
Study type: Interventional

The current study will be a randomized controlled pilot study conducted in the Midwest. Participants will be randomly assigned to a behavioral intervention or a wait-list control group, each lasting six weeks. The intervention group will first have an in-person meeting at the beginning of the intervention to discuss the study, go over movements, and discuss Zoom and WhatsApp instructions. The behavioral intervention will consist of three home-based workouts per week sent digitally and Zoom session per week that will have an exercise session and a group counseling session. Additionally, each week participants will be sent a motivational prompt via WhatsApp and will be encouraged to connect with each other about physical activity motivation, barriers, and facilitators. Acceptability, physical activity and psychosocial variables of interest will be measured via accelerometer data (via Actigraph GT3X) and self-report at baseline and six weeks (post-intervention). Focus groups will be conducted for all participants at the conclusion of the study to further assess acceptability, feasibility, and efficacy of the program.